These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25739913)

  • 1. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
    Preis M
    AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
    Comoglu T; Dilek Ozyilmaz E
    Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
    Stoltenberg I; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally disintegrating drug carriers for paediatric pharmacotherapy.
    Kean EA; Adeleke OA
    Eur J Pharm Sci; 2023 Mar; 182():106377. PubMed ID: 36634740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally disintegrating systems: innovations in formulation and technology.
    Goel H; Rai P; Rana V; Tiwary AK
    Recent Pat Drug Deliv Formul; 2008; 2(3):258-74. PubMed ID: 19075912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
    Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
    Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
    Al-Khattawi A; Mohammed AR
    Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive review on oral disintegrating films.
    Nagaraju T; Gowthami R; Rajashekar M; Sandeep S; Mallesham M; Sathish D; Kumar YS
    Curr Drug Deliv; 2013 Feb; 10(1):96-108. PubMed ID: 22920576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.
    Wiedey R; Kokott M; Breitkreutz J
    Expert Opin Drug Deliv; 2021 Dec; 18(12):1873-1890. PubMed ID: 34822316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally disintegrating films: A modern expansion in drug delivery system.
    Irfan M; Rabel S; Bukhtar Q; Qadir MI; Jabeen F; Khan A
    Saudi Pharm J; 2016 Sep; 24(5):537-546. PubMed ID: 27752225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral disintegrating tablets. A new, modern, solid dosage form].
    Popa G; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of mini-tablets as a flexible drug delivery tool.
    Mitra B; Chang J; Wu SJ; Wolfe CN; Ternik RL; Gunter TZ; Victor MC
    Int J Pharm; 2017 Jun; 525(1):149-159. PubMed ID: 28432019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
    Al-khattawi A; Mohammed AR
    Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.
    Golhen K; Buettcher M; Kost J; Huwyler J; Pfister M
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orally disintegrating tablets--advantages and drawbacks].
    Tho I
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):424-5. PubMed ID: 22353836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.